Bioasis Technologies Inc. V.BTI

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.

TSXV:BTI - Post by User

Bioasis Technologies Inc. > Strategic intersection:LSDs, inflammation, neurodegeneration

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Sep 07, 2022 4:20pm

102 Views

Post# 34947793

RE:RE:RE:Strategic intersection:LSDs, inflammation, neurodegeneration

THREE times more hedges bought last week by institutional investors than during the great financial crisis. Let's see the deal(s) signed quickly and two years of cash on the balance sheet before we find out what the capitulation stage in the showdown against Putin looks like.